Fresenius SE launches biosimilar of Roche’s Actemra
PremiumThe FlyFresenius SE launches biosimilar of Roche’s Actemra
4M ago
Fresenius SE price target raised to EUR 41 from EUR 39 at Deutsche Bank
PremiumThe Fly
Fresenius SE price target raised to EUR 41 from EUR 39 at Deutsche Bank
5M ago
Fresenius SE price target lowered to EUR 43 from EUR 44.50 at Berenberg
PremiumThe Fly
Fresenius SE price target lowered to EUR 43 from EUR 44.50 at Berenberg
5M ago
Fresenius recalling Ivenix Large Volume Pump
PremiumThe FlyFresenius recalling Ivenix Large Volume Pump
7M ago
Fresenius SE price target lowered to EUR 33 from EUR 33.50 at Morgan Stanley
PremiumThe Fly
Fresenius SE price target lowered to EUR 33 from EUR 33.50 at Morgan Stanley
7M ago
Fresenius Scraps 2023 Dividend and Bonuses to Safeguard State Aid
PremiumGlobal Markets
Fresenius Scraps 2023 Dividend and Bonuses to Safeguard State Aid
8M ago
Fresenius SE price target raised to EUR 33.50 from EUR 32.50 at Morgan Stanley
PremiumThe FlyFresenius SE price target raised to EUR 33.50 from EUR 32.50 at Morgan Stanley
12M ago
Fresenius SE price target raised to EUR 39 from EUR 28 at Deutsche Bank
PremiumThe Fly
Fresenius SE price target raised to EUR 39 from EUR 28 at Deutsche Bank
12M ago
Fresenius SE upgraded to Buy from Hold at Deutsche Bank
PremiumThe Fly
Fresenius SE upgraded to Buy from Hold at Deutsche Bank
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100